The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...

Ravi believes that while companies are making significant strides in upgrading their infrastructure, there remains a shortage ...

Otsuka’s Taiho Pharmaceutical is paying $400 million upfront to acquire Switzerland’s Araris Biotech and its antibody-drug ...

Discover why pharmaceutical-grade supplements command premium prices and whether their higher standards of purity, potency ...

Taiho Pharmaceutical has agreed to acquire Swiss-based antibody-drug-conjugate (ADC) specialist Araris Biotech for up to ...

Swiss pharmaceutical giant Novartis will watch "very carefully" how the reciprocal tariff policy proposed by the United ...

We are the problem when we would rather take the injection or the pill than make the lifestyle change. I am fortunate that I ...

Abdul Muktadir, chairman and managing director of Incepta Pharmaceuticals Ltd, has been elected president of the Bangladesh ...

Taiho Pharmaceutical Co., Ltd. (hereinafter "Taiho Pharmaceutical") and Araris Biotech AG (hereinafter "Araris"), a Swiss biotechnology company developing next-generation antibody drug conjugates ...

Who could have thought that having your seat mixed up can lead you to the love of your life?  Onyeka and Obi’s journey began ...

Australia faces a potential tariff of between 2 per cent and 8 per cent on the $30 billion of exports sold to the United ...

As Global SME of Life Science and Pharma at Tive, Alex Guillen leads sales and business development within the company's rapid-growth life sciences division. Previously, Guillen served as a Board ...